ScholarIQanswers from OpenAlex

Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway

PaperCitations, authors & open-access status

Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway have?

ScholarIQcitation count

Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway published?

ScholarIQyear

Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway has 2015 year in the ScholarIQ index.

What is the open-access status of Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway?

ScholarIQoa status

Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway has gold oa status in the ScholarIQ index.

What is the DOI of Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway?

ScholarIQdoi

The DOI for Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway is on the source record.

What is the PMID of Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway?

ScholarIQpmid

The PMID for Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway is on the source record.

What is the OpenAlex record for Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway?

ScholarIQopenalex

The OpenAlex for Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial